Bone marrow CD3 + CD56 + regulatory T lymphocytes (T R3 -56 cells) are inversely associated with activation and expansion of bone marrow cytotoxic T cells in IPSS-R very-low/low risk MDS patients.
Stefania LeoneValentina RubinoAnna Teresa PalatucciAngela GiovazzinoFlavia CarrieroGiuseppe CercielloFabrizio PaneGiuseppina RuggieroGiuseppe TerrazzanoPublished in: European journal of haematology (2022)
to the immune-regulatory network involved in MDS pathogenesis/progression. Better knowledge of the immune-mediated processes associated with the disease might improve MDS clinical management.